Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
31.20
+0.13 (0.42%)
At close: May 12, 2026

SHA:688443 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,4409,9889,20014,649--
Market Cap Growth
9.05%8.57%-37.20%---
Enterprise Value
10,4868,7207,40512,246--
Last Close Price
31.2027.2425.0939.95--
PS Ratio
41.1843.29305.7012091.50--
PB Ratio
7.976.304.335.26--
P/TBV Ratio
8.216.484.425.35--
EV/Sales Ratio
37.7437.79246.0410108.38--
Debt / Equity Ratio
0.830.670.390.2326.891.83
Net Debt / Equity Ratio
-0.66-0.73-0.76-0.8217.030.42
Net Debt / EBITDA Ratio
1.882.382.053.05-0.87-0.48
Net Debt / FCF Ratio
1.912.732.604.86-1.53-0.37
Asset Turnover
0.090.080.010.0000.05
Inventory Turnover
0.270.220.11-0.040.80
Quick Ratio
4.354.7514.1221.332.275.15
Current Ratio
4.785.1715.0522.153.166.15
Return on Equity (ROE)
-32.85%-28.87%-32.47%-56.97%-337.99%-
Return on Assets (ROA)
-11.73%-11.11%-15.62%-21.82%-38.85%-25.14%
Return on Capital Employed (ROCE)
-23.00%-21.60%-28.30%-23.00%-73.10%-32.90%
Earnings Yield
-4.93%-5.36%-8.67%-5.47%--
FCF Yield
-4.38%-4.24%-6.75%-3.20%--
Buyback Yield / Dilution
0.37%0.14%-14.63%-16.79%0.32%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.